MediWound Announces $15M Bought Deal Offering Of 1.2M Shares At $12.50/Share

The closing of the offering is expected to occur on or about November 5, 2026, subject to satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. MediWound also has granted to the underwriter a 30-day option to purchase up to an additional 180,000 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to MediWound, before deducting underwriting discounts and commissions and offering expenses and assuming no exercise of the underwriter’s option to purchase additional ordinary shares, are expected to be approximately $15 million.

MediWound intends to use the net proceeds from the offering for working capital and general corporate purposes.